Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carde

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
BMJ (Clinical Research Ed.)|July 18, 1992
Hodgkin's lymphoma. II: Treatment and delayed morbidityP Carde
Bulletin De L'Academie Nationale De Medecine|May 1, 1994
[Inhibitors of hematopoiesis: from physiology to therapy]P Carde
Leukemia|June 1, 1996
Who are the high-risk patients with Hodgkin's disease?P Carde
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Diagnostic proceduresP Carde
Bulletin Du Cancer|August 1, 1995
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?]P Carde
Bulletin De L'Academie Nationale De Medecine|January 1, 1997
[Hodgkin's disease trials conducted by the European Organization of Research and Treatment of Cancer (EORTC): their impact on the progress of cancerology]P Carde
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Chemotherapy of Hodgkin's diseaseP Carde
BMJ (Clinical Research Ed.)|July 11, 1992
Hodgkin's disease--I: Identification and classificationP Carde
Leukemia & Lymphoma|January 1, 1995
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?P Carde
European Journal of Cell Biology|May 1, 1984
Leucoplasts: a distinct kind of organelles lacking typical 70S ribosomes and free thylakoidsJ P Carde
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
BMJ (Clinical Research Ed.)|July 18, 1992
Hodgkin's lymphoma. II: Treatment and delayed morbidityP Carde
Bulletin De L'Academie Nationale De Medecine|May 1, 1994
[Inhibitors of hematopoiesis: from physiology to therapy]P Carde
Leukemia|June 1, 1996
Who are the high-risk patients with Hodgkin's disease?P Carde
Bailliere'S Clinical Haematology|September 1, 1996
Hodgkin's disease. Diagnostic proceduresP Carde
Bulletin Du Cancer|August 1, 1995
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?]P Carde
Bulletin De L'Academie Nationale De Medecine|January 1, 1997
[Hodgkin's disease trials conducted by the European Organization of Research and Treatment of Cancer (EORTC): their impact on the progress of cancerology]P Carde
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Chemotherapy of Hodgkin's diseaseP Carde
BMJ (Clinical Research Ed.)|July 11, 1992
Hodgkin's disease--I: Identification and classificationP Carde
Leukemia & Lymphoma|January 1, 1995
Should poor risk patients with Hodgkin's disease be sorted out for intensive treatments?P Carde
European Journal of Cell Biology|May 1, 1984
Leucoplasts: a distinct kind of organelles lacking typical 70S ribosomes and free thylakoidsJ P Carde
Pageof 13